Q4 2017 13F Holders as of 31 Dec 2017
-
Type / Class
-
Equity / COMMON STOCK-FO
-
Number of holders
-
33
-
Total 13F shares, excl. options
-
49.7M
-
Shares change
-
-448K
-
Total reported value, excl. options
-
$628M
-
Value change
-
-$7.33M
-
Number of buys
-
14
-
Number of sells
-
-14
-
Price
-
$12.64
Significant Holders of MYOVANT SCIENCES LTD - COMMON STOCK-FO (MYOV) as of Q4 2017
40 filings reported holding MYOV - MYOVANT SCIENCES LTD - COMMON STOCK-FO as of Q4 2017.
MYOVANT SCIENCES LTD - COMMON STOCK-FO (MYOV) has 33 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 49.7M shares
.
Largest 10 shareholders include QVT Financial LP (37.2M shares), BB BIOTECH AG (3.51M shares), RA CAPITAL MANAGEMENT, LLC (2.83M shares), NovaQuest Capital Management, L.L.C. (1.19M shares), BlackRock Inc. (1.02M shares), ADAGE CAPITAL PARTNERS GP, L.L.C. (870K shares), NORGES BANK (600K shares), EVENTIDE ASSET MANAGEMENT, LLC (552K shares), Tekla Capital Management LLC (400K shares), and D. E. Shaw & Co., Inc. (350K shares).
This table shows the top 33 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.